Dragon Pharma Adipotide 10mg Fat Reduction Peptide Vial

Adipotide (FTPP – Fat-Targeted Proapoptotic Peptide) by Dragon Pharma is a research peptide originally developed by U.S. researchers to selectively destroy white adipose tissue. Each vial contains 10 mg of lyophilized Prohibitin-targeting peptide 1 — one of the most powerful experimental fat-loss compounds ever created, capable of inducing rapid, site-specific fat reduction in stubborn areas.

What It Is

Adipotide is a peptidomimetic compound consisting of a prohibitin-targeting sequence linked to a pro-apoptotic domain. It was designed to bind specifically to the vasculature of white fat cells, triggering programmed cell death (apoptosis) exclusively in adipose tissue while leaving muscle and other organs untouched.

How It Works

Once injected, Adipotide homes in on prohibitin receptors found only on the surface of white-fat blood vessels. After binding, it blocks blood supply to adipocytes, causing them to die within days. The body then clears the dead fat cells through natural metabolic pathways — resulting in measurable fat loss within 7–28 days, especially in abdominal and visceral areas.

Adipotide Benefits

• Rapid Targeted Fat Loss: Up to 10–15% body-fat reduction in 28 days (research data)
• Visceral & Subcutaneous Reduction: Especially effective on lower abdomen and love handles
• Preserves Muscle Mass: No catabolic effect on lean tissue
• Improves Insulin Sensitivity: Significant reduction in fasting glucose and insulin resistance
• No CNS Stimulation: Works independently of appetite or metabolism stimulants

Who It's For

Advanced bodybuilders and physique athletes in contest preparation seeking the final 5–10 lbs of stubborn fat loss when diet and cardio are already maxed out. Also used in medical research settings for obesity and metabolic syndrome studies. Not intended for casual users or those new to peptides.

How to Use

Reconstitution: Add 2 ml bacteriostatic water → 5 mg/ml solution
Dosage (research protocol): 0.5–1 mg per day (0.1–0.2 ml) subcutaneous injection, 5 days ON / 2 days OFF
Cycle Length: 21–28 days maximum
Injection Timing: Morning on empty stomach for optimal targeting

Stacking Suggestions

• Contest Shred Stack: Adipotide + Tesamorelin + Fragment 176-191
• Metabolic Recomp: Adipotide + Cardarine GW-501516
• Peptide Synergy: Adipotide + MOTS-c + AOD-9604

Side Effects

• Increased thirst and frequent urination (first 3–5 days)
• Mild nausea or fatigue at higher doses
• Possible dehydration — drink 5–6 L water daily
• Kidney stress in prolonged or high-dose use (monitor creatinine)

Post Cycle Therapy (PCT)

Not required — Adipotide does not affect the HPTA axis or suppress natural hormone production.